Corteva shares plunge 23% as earnings miss and weaker Brazil demand force guidance cut

Corteva (CTVA) shares dropped 23% to $9.40 after missing Q3 earnings and revenue estimates. Adjusted operating earnings were $0.06 per share vs. $0.10 expected. Revenue fell 9% YoY to $1.59B. The company cut its 2026 EPS guidance to $0.76-$0.80, citing weaker demand in Latin America, especially Brazil.

Original reporting
Published Nov 12, 2026, 3:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 3:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Corteva shares plunge 23% as earnings miss and weaker Brazil demand force guidance cut — source image
Decision brief

The 30-second read

$CTVABearishHigh
01

Why it matters

The earnings miss and guidance cut are the primary catalysts for the 23% share decline, indicating heightened short‑term risk.

02

Market read

The sharp price move and guidance reduction make this a high‑impact earnings event for traders.

03

What to watch

Seasonal inventory adjustments and potential policy support for farmers could mitigate some downside.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Corteva Inc (CTVA) is a major U.S. agricultural chemicals company. The report covers its Q3 results and FY2026 guidance revision.

Company-level read

Ticker impact

$CTVABearishHigh confidence
Context

Corteva reported a Q3 earnings miss, revenue decline and cut full-year guidance, causing a 23% share plunge.

Expected impact

likely pressure as the market prices in weaker demand and lower earnings expectations

Evidence & confidence

The 23% drop reflects immediate reaction; guidance cut to $0.76‑$0.80 signals continued earnings weakness.

Market effects

Agricultural chemicals sector may face broader pressure from weak Latin America demand.

Brazilian agribusiness exposure could see heightened risk.

Potential ripple to global crop‑protection suppliers and related commodity markets.

Counterpoint

If the market overreacts, a deeper pullback could set up a buying opportunity at lower valuations.

Key entities

  • Corteva Inc

    U.S. agricultural chemicals producer reporting Q3 results.

Related articles

$CTVAHighAI 8/10

Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook

Corteva, Inc. (CTVA) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook • Third-quarter results reflect strong new product sales growth and continued operational excellence, helping mitigate broader market headwinds • Pricing pressure was concentrated in North America an

$CTVAMed

Mizuho reiterates Corteva stock rating on challenging crop market

Mizuho reiterated an Outperform rating and $16.00 price target for Corteva Inc. (CTVA) after its latest results. The stock is undervalued at $12.14, with a market cap of $8.1 billion. Corteva reported a 17% YoY decline in EBITDA, with regional sales varying. The company reduced its 2026 EBITDA guidance due to challenging market conditions, particularly in Brazil. Q3 results missed expectations, with revenue down 9% YoY.

$CTVAHighAI 8/10

Corteva shares fall 6% on worse-than-expected Q3 results

Corteva Inc. (CTVA) reported Q3 earnings of $0.06 per share, missing estimates of $0.10, and revenue of $1.59B, below the $1.77B forecast. Shares fell 6.4%. Full-year 2026 guidance adjusted, with EPS midpoint at $0.78, above consensus, but EBITDA guidance lowered due to Brazil market conditions. Revenue declined 9% YoY, with Latin America sales down 31% and North America up 7%.

$CTVAHighAI 8/10

Why is Corteva stock sliding today?

Corteva stock fell 6.4% after reporting Q3 results below expectations, with net sales down 9% YoY and a GAAP loss of $54M. Adjusted EPS dropped 57% to $0.06. The company cited weak Latin America performance and revised 2026 guidance lower, citing Brazil market conditions. Analysts had already cut EPS estimates and price targets. The S&P 500 was flat, indicating the drop was company-specific.